Congressional Oversight

Fauci Returns to Senate Testimony as Rand Paul Prepares New Hearing

Anthony Fauci's forthcoming Senate appearance, combined with newly surfaced diary entries cited in published reporting, renews scrutiny of congressional oversight over federal pandemic...

The Congressional Times · July 27, 2026

Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases (NIAID), is scheduled to again appear before a Senate committee where Sen. Rand Paul (R-KY) holds a prominent oversight role, according to reporting by the New York Post dated July 27, 2026. The Post cited diary entries attributed to Fauci as part of its coverage. The Congressional Times has not independently reviewed those diary documents; their full contents remain unverified by this publication pending access to primary records.

Fauci led the federal COVID-19 response as NIAID director from the pandemic's outset in early 2020 until his retirement in December 2022, a tenure documented in congressional testimony transcripts available through the Senate Health, Education, Labor, and Pensions (HELP) Committee record. Sen. Paul, a member of that committee, conducted multiple exchanges with Fauci during that period, including a July 20, 2021 hearing in which Paul questioned NIAID grant funding routed through EcoHealth Alliance to the Wuhan Institute of Virology — a line of inquiry preserved in the official congressional record (S. Hrg. 117-185).

The specific date, committee, and format of the forthcoming hearing have not been confirmed in a public committee schedule as of July 27, 2026. The Senate HELP Committee's official calendar, accessible at help.senate.gov, would be the authoritative source for confirmation of witness lists, dates, and subject matter. A formal committee notice would also specify whether Fauci's appearance is voluntary or compelled by subpoena.

Questions that remain unanswered in the public record include: whether Fauci has been subpoenaed or invited voluntarily; which specific aspects of pandemic oversight the committee intends to examine; and whether any new documentary evidence beyond the diary entries cited by the Post will be introduced into the hearing record. The relevant documents that would resolve these questions are a committee subpoena (if issued), a witness notification letter, and the formal hearing notice published by the committee chair's office.

We Follow the Data, Not the Narrative

The Congressional Times exists because public records are public — and the analysis built from them should not be exclusive to those who can afford $60,000-a-year intelligence subscriptions.

Every story published in The Congressional Times is sourced to a verifiable public record: a court filing, a Senate lobbying disclosure, an FEC contribution record, a USASpending contract, or a verified news report. We state our sources inline. We show our math. When we are wrong, we say so publicly.

We do not editorialize in news coverage. We do not use loaded language. Both political parties are held to identical standards.

The Follow the Money investigations are the heart of this publication. Each begins with Gab-E Political Intelligence running against 10+ million government records before a single word of editorial is written.

How We Source, Verify, and Correct Our Work

Every factual claim in a Congressional Times story is checked against a primary source: a government filing, a court record, a direct quote, before publication. When a claim can't be verified or doesn't hold up as originally reported, we drop it or reframe it. We do not publish disputed claims as settled fact.

When we get it wrong: we correct the story directly, note the correction and date at the bottom of the piece, and update the record. We do not quietly edit and move on.

Bylines: stories with a named byline are written and fact-checked by that person. Stories without a byline are sourced from Gab-E Political Intelligence, our automated research platform, and are labeled as such.

Ownership: The Congressional Times is published by Gab-E Holdings LLC. Gab-E, our intelligence platform, powers our sourcing and research pipeline.

Corrections or concerns: support@gab-e.com